Avatrombopag
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-13463-1MG | 1 mg | 109,00 | Add | |
| HY-13463-5MG | 5 mg | 204,00 | Add | |
| HY-13463-10MMO | 10mM/1mL | 285,00 | Add | |
| HY-13463-10MG | 10 mg | 317,00 | Add | |
| HY-13463-50MG | 50 mg | 925,00 | Add | |
| HY-13463-100MG | 100 mg | 1'472,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Avatrombopag (AKR-501) is an orally active, nonpeptide thrombopoietin (TPO) receptor agonist (EC50=3.3 nM). Avatrombopag mimics the biological activities of TPO. Avatrombopag increases platelet production by activating the intracellular signaling system, and promotes production of platelets and megakaryocytes from hemopoietic precursor cells. Avatrombopag is a substrate of cytochrome P450 (CYP) 2C9 and CYP3A[1][2][3].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Inflammation/Immunology, Cancer, Immunology/Inflammation |
| Format | Solubility: DMSO : 8.33 mg/mL (ultrasonic;warming;heat to 60°C) |
| Grade | Clinical information: Launched |
| Purity | 99.83% |
| Molecular Formula | C29H34Cl2N6O3S2 |
| Molecular Weight | 649.65 |
| CAS-Number | 570406-98-3 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
